BLDR's fourth-quarter 2024 results are likely to reflect tepid volume trends amid macro risks. Dive in to know more about the factors impacting...

Amicus' fourth-quarter 2024 earnings miss estimates while revenues beat the same.

AVNT's fourth-quarter organic sales rise 5% year over year aided by growth in all geographic regions.

Incyte reports mixed fourth-quarter 2024 results as earnings miss estimates while revenues beat the same. Jakafi and Opzelura drive year-over-year...

ON Semiconductor's fourth-quarter 2024 performance reflects sluggishness across the automotive and industrial end markets.

RARE reports mixed fourth-quarter results, as earnings miss estimates while revenues beat the same. Product sales increase year over year.

TreeHouse Foods Q4 results reflect lower net sales but higher earnings. The gross margin expands y/y due to the effective execution of supply-chain...

ATUS reported a top-line contraction year over year in the fourth quarter of 2024, owing to declining net sales in multiple segments.

Blueprint Medicines' fourth-quarter earnings and sales miss estimates. Shares of the company decline following the announcement.

FARM's second-quarter results reflect a net sales increase, improved margins and ongoing efforts to drive growth and efficiency.